MacroGenics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	66.52	57.22	182.84	100.96	108.88	123.47
Short-Term Investments	87.71	132.7	18.83	128.85	45.46	120.15
Cash & Short-Term Investments	154.23	189.91	201.67	229.81	154.35	243.62
Cash Growth	0.06%	-5.83%	-12.24%	48.89%	-36.64%	-10.61%
Accounts Receivable	10.43	13.37	4.31	10.37	56.22	10.39
Inventory	9.5	7.91	-	1.22	1.45	4.39
Other Current Assets	8.37	8.75	11.51	9.95	10.16	21.17
Total Current Assets	182.52	219.94	217.49	251.34	222.18	279.56
Net Property, Plant & Equipment	33.97	35.52	42.61	45.69	56.91	54.29
Other Long-Term Assets	1.38	1.39	1.56	1.39	1.38	1.4
Total Assets	217.87	256.85	261.66	298.42	280.47	335.25
Accounts Payable	4.29	4.79	5.01	6.44	4.9	15.5
Accrued Expenses	18.45	22.23	29.33	24.24	29	33.76
Current Portion of Leases	5.21	5.18	4.86	3.78	4.73	4.68
Unearned Revenue	67.99	10.92	16.32	21.65	9.99	20.65
Total Current Liabilities	95.94	43.12	55.53	56.11	48.61	74.58
Long-Term Leases	31.3	31.59	32.6	30.2	30.11	20.79
Other Long-Term Liabilities	69.44	126.56	57.47	59.5	59.74	0.26
Total Long-Term Liabilities	100.74	158.14	90.07	89.7	89.84	21.05
Total Liabilities	196.68	201.26	145.6	145.81	138.46	95.63
Common Stock	0.64	0.63	0.63	0.62	0.62	0.61
Additional Paid-in Capital	1,302	1,299	1,285	1,255	1,235	1,213
Accumulated Other Comprehensive Income	-0.03	0.03	0	-0.01	-0.01	-0.06
Retained Earnings	-1,281	-1,244	-1,170	-1,103	-1,094	-973.94
Shareholders' Equity	21.2	55.59	116.06	152.61	142.01	239.62
Total Liabilities & Equity	217.87	256.85	261.66	298.42	280.47	335.25
Total Debt	36.51	36.76	37.46	33.97	34.83	25.47
Net Cash (Debt)	117.72	153.15	164.21	195.83	119.51	218.15
Net Cash Growth	-23.14%	-6.73%	-16.15%	63.86%	-45.21%	-10.33%
Net Cash Per Share	1.86	2.42	2.62	3.16	1.95	3.64
Book Value	21.2	55.59	116.06	152.61	142.01	239.62
Book Value Per Share	0.33	0.88	1.85	2.46	2.31	4.00
Tangible Book Value	21.2	55.59	116.06	152.61	142.01	239.62
Tangible Book Value Per Share	0.33	0.88	1.85	2.46	2.31	4.00

SEC Filings: 10-K · 10-Q